PUNE, India, May 24, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Comparator Drug Sourcing Market by End-user (Drug Producers/Manufacturers, CMO, Academic, and Research Institute), and Region: Size, Share, Trends and Opportunity Analysis, 2023-2031“, the market size was USD 974 million in 2022 and is expected to reach USD … Read more
STOCKHOLM, May 24, 2023 /PRNewswire/ — RaySearch Laboratories AB (publ) is proud to announce that the oncology information system RayCare®* can connect to Varian TrueBeam® linear accelerators. This is the result of the interoperability agreement with Varian Medical Systems that was signed in 2020. The ability to schedule radiation treatments and keep track of the treatment … Read more
Sustained Investment in Public Health Infrastructure and Preparedness is Needed to Protect Lives During Disease Outbreaks and Natural Disasters WASHINGTON, May 24, 2023 /PRNewswire/ — As infectious disease outbreaks and extreme weather events threaten the health of more Americans, a new report shows the need for strengthened national and state public health emergency preparedness. Ready … Read more
ZUG, Switzerland, May 24, 2023 /PRNewswire/ — Ductor, a leading circular biotechnology company within biogas and organic fertilizers, and TotalEnergies, the global multi-energy company, today announce a new commercial and financial partnership with joint development of production facilities and TotalEnergies equity ownership in Ductor. The two companies have agreed to form a joint venture to … Read more
SHANGHAI, May 24, 2023 /PRNewswire/ — BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the Investigational New Drug (IND) application for the clinical trial of its proprietary BRY812, a novel antibody-drug conjugate (ADC) targeting human LIV-1 for the treatment of advanced malignant tumors, has been accepted by the China National Medical Products Administration (NMPA) (Acceptance … Read more
KYOTO, Japan, 24. Mai 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (im Folgenden als das Unternehmen bezeichnet) mit Sitz in Muko City, Präfektur Kyoto, Japan, ist stolz darauf, in diesem Jahr sein 50-jähriges Jubiläum in der Produktion von Blutdruckmessgeräten zu feiern. Seit der Einführung des ersten manuellen Blutdruckmessgeräts und des Blutdruckmessgeräts mit Manometer im Jahr … Read more
SHANGHAI, May 24, 2023 /PRNewswire/ — BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the Investigational New Drug (IND) application for the clinical trial of its proprietary BRY812, a novel antibody-drug conjugate (ADC) targeting human LIV-1 for the treatment of advanced malignant tumors, has been accepted by the China National Medical Products Administration (NMPA) (Acceptance … Read more
Après les acquisitions de DS InPharmatics (DSI) en 2021 et de Zwiers Regulatory Consultancy en 2022, ProductLife Group (PLG), un fournisseur spécialisé dans les services de réglementation et de conformité pour l’industrie des sciences de la vie, renforce davantage ses capacités à soutenir les activités de développement de produits pour ses clients, en acquérant la … Read more
KYOTO, Japon, 24 mai 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (ci-après appelée la Société), basée à Muko City, préfecture de Kyoto, au Japon, est fière d’annoncer la célébration, cette année, de son 50e anniversaire d’activité dans le secteur de la production de moniteurs de pression artérielle. Depuis l’introduction de son premier tensiomètre manuel et manométrique en … Read more
Danish start-up developing immunotherapies designed to fight the tumors from within Financing supports GMP and toxicology studies and will advance InProTher’s first-in-class cancer immunotherapy into First-in-Human clinical trials Strengthens team with appointment of industry heavyweights Dr. Sven Rohmann as Chairman and Dr. Hamina Patel as CMO COPENHAGEN, Denmark, May 24, 2023 /PRNewswire/ — InProTher, an … Read more